Federal health officials have approved the first oral treatment for postpartum depression.
FILE - An estimated one in 7 women suffer from postpartum depression.
FILE - An estimated one in 7 women suffer from postpartum depressionÖsterreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Opinion | Washington Stages a Peacetime Fiscal BlowoutFrom WSJopinion: The federal budget deficit is 131% higher than a year ago so far in fiscal 2023, despite a growing economy and no national emergency
Weiterlesen »
First-ever postpartum depression pill, Zurzuvae, approved by FDAThe FDA on Friday approved the first pill to treat postpartum depression, a condition that data shows affects around 1 in 7 women in the United States.
Weiterlesen »
FDA OKs Talquetamab, a First-in-Class Multiple Myeloma DrugThe FDA has granted accelerated approval to talquetamab-tgvs, a first-in-class bispecific antibody targeting the GPRC5D receptor, for heavily pretreated adults with relapsed or refractory multiplemyeloma. MedicalNews
Weiterlesen »
FDA Program Collects Birth Control Data from TeensA federal program is collecting a trove of intimate monthly birth control data on hundreds of thousands of patients, many of whom are teens, including the results of mandatory pregnancy tests.
Weiterlesen »
Nail Care ProductsPlanning on getting a manicure? Beware-some nail hardeners may contain harmful ingredients that may damage nails and cause them to break. For more information on how to use nail products safely, see nails summerfun safety
Weiterlesen »